Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Biogen Inc (BIIB) vs VF Corp (VFC) Price & Performance

Biogen IncTrade

Price performance (Past 24H)

Key statistics

Biogen Inc vs VF Corp — how do they compare? Biogen Inc trades at $202.7 (market cap $30.13B), while VF Corp trades at $14.9 (market cap $5.81B). The key difference: Biogen Inc is far larger — about 5.2× VF Corp's market cap, and VF Corp pays a 2.44% dividend while Biogen Inc pays none. Which is the better fit depends on your goals.

BIIBVFC
Market Cap
$30.13B$5.81B
Sector
HealthConsumer Cyclical
52-Week High
$216.63$21.55
52-Week Low
$128.93$12.21
Enterprise Value
$37.20B$10.09B
Dividend Yield
2.44%

Returns comparison

Trailing returns across standard periods

About Biogen Inc

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021.

Read more on BIIB

About VF Corp

VF designs, produces, and distributes branded apparel and accessories. Its largest apparel categories include action sports, outdoor, and workwear. Its portfolio of about a dozen brands includes Vans, The North Face, Timberland, Supreme, and Dickies. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and branded stores owned by the company and partners. The company has grown through multiple acquisitions and traces its roots to 1899.

Read more on VFC